Genmab — Marts 2021
-
Genmab keeping dates for GEN1046 in clinicaltrials as they were , just adding a few trial sites, so no reason to worry about Covid delays
for now https://clinicaltrials.gov/ct2/history/NCT03917381?A=11&B=12&C=merged#StudyPageTop -
Legolas det er der sikkert også nogen der gerne vil, men hvornår når vi bunden, det er spørgsmålet. Et langt stykke hen ad vejen kan man supplere når aktien falder, men mellem 50 og 100 kurspoint om dagen i uger, kan man ikke køber sig ud af. Jeg har snar så mange, at jeg må lade mig registrere som storaktionær, overdrivelse kan forekomme.
-
Er der egentlig kommet pdufa på tisotumab?
-
application was sent feb 10th - so still early days
-
i'm just keeping my fingers crossed for some kind of news to stop the free fall. Reversing the trend seems a bit much to ask for...
-
isn't it normally 60 days for application review from the FDA?
-
Aktien er ikke så sexet pt. Jeg tror den skal under 2000 i morgen.
-
Jeg tør ikke rigtig spå mere. Det virker som om, der er større kræfter, der kører rundt med aktien på en måde, som vi ikke rigtig kan gennemskue
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind